These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 38791957)

  • 41. Medicinal Chemistry Perspectives on Recent Advances in Src Kinase Inhibitors as a Potential Target for the Development of Anticancer Agents: Biological Profile, Selectivity, Structure-Activity Relationship.
    Teli G; Pal R; Maji L; Sengupta S; Raghavendra NM; Matada GSP
    Chem Biodivers; 2023 Sep; 20(9):e202300515. PubMed ID: 37563848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthetic strigolactone analogues reveal anti-cancer activities on hepatocellular carcinoma cells.
    Hasan MN; Choudhry H; Razvi SS; Moselhy SS; Kumosani TA; Zamzami MA; Omran Z; Halwani MA; Al-Babili S; Abualnaja KO; Al-Malki AL; Alhosin M; Asami T
    Bioorg Med Chem Lett; 2018 Apr; 28(6):1077-1083. PubMed ID: 29456109
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities,
    Alam MS; Lee DU
    Med Chem; 2022; 19(1):47-63. PubMed ID: 35490310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design of Lamivudine Loaded Nanoparticles for Oral Application by Nano Spray Drying Method: A New Approach to use an Antiretroviral Drug for Lung Cancer Treatment.
    Öztürk AA; Namlı İ; Güleç K; Görgülü Ş
    Comb Chem High Throughput Screen; 2020; 23(10):1064-1079. PubMed ID: 32209039
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-inflammatory drugs in the 21st century.
    Rainsford KD
    Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In Search of Panacea-Review of Recent Studies Concerning Nature-Derived Anticancer Agents.
    Przystupski D; Niemczura MJ; Górska A; Supplitt S; Kotowski K; Wawryka P; Rozborska P; Woźniak K; Michel O; Kiełbik A; Bartosik W; Saczko J; Kulbacka J
    Nutrients; 2019 Jun; 11(6):. PubMed ID: 31242602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthetic and Medicinal Perspective of Fused-Thiazoles as Anticancer Agents.
    Pawar S; Kumar K; Gupta MK; Rawal RK
    Anticancer Agents Med Chem; 2021; 21(11):1379-1402. PubMed ID: 32723259
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anticancer therapeutics: "Addictive" targets, multi-targeted drugs, new drug combinations.
    Broxterman HJ; Georgopapadakou NH
    Drug Resist Updat; 2005 Aug; 8(4):183-97. PubMed ID: 16154800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advances in the development of hybrid anticancer drugs.
    Fortin S; Bérubé G
    Expert Opin Drug Discov; 2013 Aug; 8(8):1029-47. PubMed ID: 23646979
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anticancer Properties of a New Hybrid Analog AD-013 Combining a Coumarin Scaffold with an α-methylene-δ-lactone Motif.
    Dlugosz A; Gach-Janczak K; Szymanski J; Deredas D; Krawczyk H; Janecki T; Janecka A
    Anticancer Agents Med Chem; 2018; 18(3):450-457. PubMed ID: 28933263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Naturally Sourced CDK Inhibitors and Current Trends in Structure-Based Synthetic Anticancer Drug Design by Crystallography.
    Nandi S; Dey R; Dey S; Samadder A; Saxena AK
    Anticancer Agents Med Chem; 2022; 22(3):485-498. PubMed ID: 34503422
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
    Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
    Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anticancer properties of chimeric HDAC and kinase inhibitors.
    Biersack B; Polat S; Höpfner M
    Semin Cancer Biol; 2022 Aug; 83():472-486. PubMed ID: 33189849
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
    Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
    Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery and Development of Topoisomerase Inhibitors as Anticancer Agents.
    Kathiravan MK; Kale AN; Nilewar S
    Mini Rev Med Chem; 2016; 16(15):1219-1229. PubMed ID: 27549098
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bestowal of Quinazoline Scaffold in Anticancer Drug Discovery.
    Das R; Mehta DK; Dhanawat M
    Anticancer Agents Med Chem; 2021; 21(11):1350-1368. PubMed ID: 32593282
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Virtual Screening for Biomimetic Anti-Cancer Peptides from
    Chantawannakul J; Chatpattanasiri P; Wattayagorn V; Kongsema M; Noikaew T; Chumnanpuen P
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641308
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current developments of coumarin-based anti-cancer agents in medicinal chemistry.
    Emami S; Dadashpour S
    Eur J Med Chem; 2015 Sep; 102():611-30. PubMed ID: 26318068
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.